Array BioPharma (ARRY) Posts Mixed Q3 Results
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.12 -7.41%
Revenue Growth %: -12.3%
Financial Fact:
Weighted average shares outstanding - basic (in shares): 145.1M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -12.3%
Financial Fact:
Weighted average shares outstanding - basic (in shares): 145.1M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Array BioPharma, Inc. (Nasdaq: ARRY) reported Q3 loss of $0.20, $0.05 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $17.8 million versus the consensus estimate of $19.58 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- BlackBerry surges on earnings beat and strong cash flow
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
